Liver Fibrosis and Steatosis in dm Non Invasive Evaluation
NCT05605717 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-11-04
Summary
Non invasive evaluation of liver fibrosis and steatosis in type 2 diabetic patient in Assiut University hospitals
Conditions
Interventions
- RADIATION
-
Fibroscan
Liver fibroscan and ultrasonography
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Hossam Mahmoud Abdelwahab, PhD · Lecturer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2023-09-01
- Completion
- 2023-09-01
Countries
- Egypt
Study Locations
More Related Trials
-
Liver Fibrosis Assessment in Diabetic Patients
NCT06694974 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV
NCT06589167 ·Status: NOT_YET_RECRUITING
-
Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology
NCT06166511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy
NCT03612973 ·Status: COMPLETED ·Phase: NA
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes
NCT06456970 ·Status: NOT_YET_RECRUITING
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA
-
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
NCT04720560 ·Status: RECRUITING
-
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424 ·Status: COMPLETED ·Phase: NA
-
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 ·Status: COMPLETED
-
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
NCT03250572 ·Status: COMPLETED
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
NCT03245606 ·Status: COMPLETED
-
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
NCT02575625 ·Status: UNKNOWN ·Phase: NA
-
Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
NCT05790057 ·Status: UNKNOWN
-
Relation Between NAFLD and BM DENSITY
NCT06038253 ·Status: NOT_YET_RECRUITING
-
Identification and Validation of Noninvasive Biomarkers of the Diagnosis and Severity of NASH in Type 2 Diabetics
NCT03634098 ·Status: COMPLETED ·Phase: NA
-
AI Models vs Non-Invasive Fibrosis Scores in MAFLD Diagnosis
NCT07305636 ·Status: COMPLETED
-
Liver Fibrosis in Peri-menopausal Women
NCT03602573 ·Status: UNKNOWN
-
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
NCT05105828 ·Status: COMPLETED
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
NCT01360879 ·Status: UNKNOWN